Eighth Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases
April 27-28, 2012
- Conference Brochure (PDF)
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine and Kennedy Fellows Association. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description
Now in its eighth year, this two-day symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Objectives
After attending this activity, the participant will demonstrate the ability to:
- Review new guidelines in the diagnosis and treatment of rheumatic diseases
- Discuss the use of biologic agents in the treatment of rheumatoid arthritis
- Appreciate new treatment options for patients with psoriatic arthritis
- Discuss new and emerging issues in the management of osteoporosis
- Identify major issues related to the management vasculitis
- Appraise current management approaches and controversies in the diagnosis and treatment of ankylosing spondylitis
- Discuss treatment strategies in systemic lupus erythematosus
- Discuss basic immunology and its role in auto-immune diseases
- Review current treatment in the scleroderma patient
Policy On Speaker And Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
